Based on ratings from 11 stock analysts, the Patterson Cos Inc stock price is expected to increase by 12.24% in 12 months. This is calculated by using the average 12-month stock price forecast for Patterson Cos Inc. The lowest target is $27.00 and the highest is $37.00. Please note analyst price targets are not guaranteed and could be missed completely.
Patterson Cos Inc has a total of 11 Wall St Analyst ratings. There are 3 buy ratings, 8 ratings, and 0 sell ratings. Since most analysts have a buy consensus rating, the expectation is that Patterson Cos Inc will outperform the market. Investors shouldn't rely purely on analyst ratings; we encourage investors to also take a look at the fundamental and technical analysis in their due diligence.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
jason bednar Piper Sandler | Buy | $34.0 | rated | Jan 23, 2024 |
brandon couillard Jefferies | Hold | $28.0 | maintained | Dec 8, 2023 |
jonathan block Stifel Nicolaus | Hold | $30.0 | maintained | Dec 1, 2023 |
elizabeth anderson cfa Evercore ISI | Hold | $27.0 | maintained | Dec 1, 2023 |
jeff johnson Robert W. Baird | Hold | $32.0 | maintained | Nov 30, 2023 |
kevin caliendo UBS | Hold | $29.0 | maintained | Nov 30, 2023 |
nathan rich Goldman Sachs | Hold | $30.0 | maintained | Nov 30, 2023 |
erin wright Morgan Stanley | Hold | $35.0 | maintained | Nov 30, 2023 |
john stansel J.P. Morgan | Hold | $31.0 | maintained | Nov 30, 2023 |
michael cherny Bank of America Securities | Buy | $37.0 | reiterated | Nov 29, 2023 |
allen lutz Bank of America Securities | Buy | $37.0 | reiterated | Nov 29, 2023 |
lisa gill J.P. Morgan | Hold | $34.0 | initiatedcoverage | Nov 10, 2023 |
a.j. rice Credit Suisse | Buy | $38.0 | maintained | Aug 31, 2023 |
michael minchak J.P. Morgan | Hold | $31.0 | maintained | Jun 23, 2023 |
rachel vatnsdal J.P. Morgan | Hold | $31.0 | maintained | Jun 23, 2023 |
jonathan yong Credit Suisse | Buy | $38.0 | maintained | Jun 22, 2023 |
matt miksic Credit Suisse | Buy | $36.0 | maintained | Mar 3, 2022 |
steven valiquette Barclays | Sell | $27.0 | maintained | Feb 2, 2021 |
glen santangelo Jefferies | Hold | None | downgraded | Nov 10, 2020 |
sarah james Barclays | Hold | $22.0 | initiatedcoverage | Jul 7, 2020 |
Patterson Companies, Inc. engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems. It also provides a range of related services comprising software and design services, maintenance and repair, and equipment financing. The Animal Health segment distributes biologicals, pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritional's, consumable supplies, equipment, and software, as well as value-added services. This segment also provides private label portfolio of products to veterinarians, producers, and retailers under the Aspen, First Companion, and Patterson Veterinary brands. The Corporate segment offers customer financing services; and sells other miscellaneous products. It serves dentists, laboratories, institutions, other healthcare professionals, veterinarians, other animal health professionals, production animal operators, and animal health product retailers. The company was formerly known as Patterson Dental Company and changed its name to Patterson Companies, Inc. in June 2004. Patterson Companies, Inc. was founded in 1877 and is headquartered in Saint Paul, Minnesota.
When did it IPO
1992
Staff Count
7,600
Country
United States
Sector/Industry
Healthcare/Medical Distribution
CEO
Mr. Donald J. Zurbay
Market Cap
$2.63B
In 2023, PDCO generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that PDCO's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2019
Revenue From 2020
Revenue From 2021
Revenue From 2022
PLXS-USD
$95.43
JAMF-USD
$20.7
GDRX-USD
$6.54
BEAM-USD
$33.54
DORM-USD
$82.82
MYRG-USD
$154.12